Weight Zen

Weight Zen operates as a telehealth-focused weight management clinic serving patients throughout New York, NY, under the medical direction of Dr. Daniel J. Rosen, a board-certified bariatric surgeon. The practice combines surgical weight loss expertise with medical weight management protocols, offering patients access to GLP-1 receptor agonist peptide therapies without requiring in-person office visits. Dr. Rosen's dual background in bariatric surgery and non-surgical weight management allows the clinic to provide medically supervised peptide programs informed by surgical-level metabolic understanding, creating treatment plans that address both immediate weight reduction goals and long-term metabolic health.

The clinic's peptide therapy program centers on three FDA-approved GLP-1 medications: Liraglutide, Semaglutide, and Tirzepatide. Liraglutide is typically prescribed as a daily subcutaneous injection for patients requiring gradual appetite regulation and glycemic control, while Semaglutide offers once-weekly dosing for patients seeking convenience alongside weight reduction. Tirzepatide, the newest addition to the clinic's formulary, functions as a dual GIP/GLP-1 receptor agonist and is reserved for patients who may benefit from enhanced metabolic effects beyond standard GLP-1 therapy alone. Dr. Rosen determines peptide selection based on individual metabolic profiles, weight loss history, comorbid conditions such as type 2 diabetes or hypertension, and patient lifestyle factors that affect medication adherence. Dosing protocols follow evidence-based titration schedules, with adjustments made through telehealth follow-ups to optimize efficacy while minimizing gastrointestinal side effects common to this medication class.

Dr. Daniel J. Rosen brings surgical precision to medical weight management, having completed fellowship training in bariatric and metabolic surgery. His clinical approach integrates surgical consultation for patients considering procedures like sleeve gastrectomy or hernia repair with medical management options for those pursuing non-surgical pathways. This dual expertise proves particularly valuable for post-bariatric surgery patients experiencing weight regain, individuals with surgical contraindications, and those seeking to avoid operative intervention. The clinic's telehealth model allows Dr. Rosen to extend his New York-based practice to patients across the state who face geographic barriers to specialized weight management care, with phone and video consultations replacing traditional office visits for initial evaluations, prescription management, and ongoing monitoring.

Patients beginning treatment at Weight Zen complete an initial telehealth consultation that includes review of medical history, current medications, previous weight loss attempts, and metabolic laboratory work ordered through local facilities. Dr. Rosen evaluates candidacy for peptide therapy based on BMI thresholds, presence of weight-related comorbidities, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Once approved, patients receive prescriptions through partner pharmacies with medications shipped directly to their homes, along with injection technique instructions and protocols for managing common side effects like nausea or constipation. Follow-up consultations occur at intervals determined by medication type and individual response, typically every four weeks during dose titration phases and every eight to twelve weeks during maintenance. The clinic monitors weight trends, side effect profiles, and metabolic markers, adjusting treatment intensity or transitioning between peptides as clinical response dictates.

Weight Zen's telehealth infrastructure addresses a specific gap in New York's weight management landscape by providing bariatric surgery-level expertise through remote consultation, eliminating travel requirements for patients in outer boroughs or upstate regions. The clinic's 4.6-star rating across 58 Google reviews reflects patient experiences with surgical outcomes, hernia repairs, and the accessibility of phone-based consultations, indicating that the practice serves both surgical and medical weight management populations. For patients seeking peptide therapy without the overhead of traditional medical office visits, Weight Zen offers a streamlined model where bariatric surgical knowledge informs conservative medical treatment, creating a hybrid approach that leverages Dr. Rosen's operative experience to guide non-operative interventions. This structure particularly benefits patients evaluating whether to pursue surgery or medical management, as they receive counsel from a provider qualified to offer both pathways based on clinical appropriateness rather than practice limitations.